Related references
Note: Only part of the references are listed.Human dendritic cells in cancer
Egle Kvedaraite et al.
SCIENCE IMMUNOLOGY (2022)
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
M. Maio et al.
ANNALS OF ONCOLOGY (2022)
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment
Neal Akhave et al.
LUNG CANCER (2022)
Importance of the endometrial immune environment in endometrial cancer and associated therapies
Hannah van der Woude et al.
FRONTIERS IN ONCOLOGY (2022)
Type 1 conventional dendritic cells: ontogeny, function, and emerging roles in cancer immunotherapy
Shengbo Zhang et al.
TRENDS IN IMMUNOLOGY (2021)
Defining Immunogenic and Radioimmunogenic Tumors
Terry R. Medler et al.
FRONTIERS IN ONCOLOGY (2021)
Infiltration of CD1a-positive dendritic cells in advanced laryngeal cancer correlates with unfavorable outcomes post-laryngectomy
Akimichi Minesaki et al.
BMC CANCER (2021)
CD1a-and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients
Maria Belen Giorello et al.
BREAST CANCER (2021)
Immunotherapy in endometrial cancer: rationale, practice and perspectives
Wenyu Cao et al.
BIOMARKER RESEARCH (2021)
The role of dendritic cells in cancer and anti-tumor immunity
Ariel E. Marciscano et al.
SEMINARS IN IMMUNOLOGY (2021)
DC-SIGN-LEF1/TCF1-miR-185 feedback loop promotes colorectal cancer invasion and metastasis
Menglang Yuan et al.
CELL DEATH AND DIFFERENTIATION (2020)
Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker
Garth R. Fraga et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study
Nilofer S. Azad et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Tissue Infiltrating Immune Cells as Prognostic Biomarkers in Endometrial Cancer: A Meta-Analysis
Fang Guo et al.
DISEASE MARKERS (2020)
Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer
Bi-Lan Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
The CD83 Molecule - An Important Immune Checkpoint
Linda Grosche et al.
FRONTIERS IN IMMUNOLOGY (2020)
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner et al.
FRONTIERS IN IMMUNOLOGY (2020)
Dendritic cell therapy in cancer treatment; the state-of-the-art
Mahsa Sadeghzadeh et al.
LIFE SCIENCES (2020)
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
Ziduo Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Thiago A. Patente et al.
FRONTIERS IN IMMUNOLOGY (2019)
Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c+ Conventional Dendritic Cell Subsets Mediated by CD103 and CD205
Yong Lu et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD11c-AND CD123-POSITIVE DENDRITIC CELLS IN DEVELOPMENT OF ANTITUMOUR IMMUNITY IN NON-SMALL CELL LUNG CANCER PATIENTS
Plamen Minkov et al.
POLISH JOURNAL OF PATHOLOGY (2019)
A decreased peritumoral CD1a+cell number predicts a worse prognosis in oral squamous cell carcinoma
Juscelino F. Jardim et al.
HISTOPATHOLOGY (2018)
Plasmacytoid dendritic cell in immunity and cancer
Dana Mitchell et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Molecular Genetics of Endometrial Carcinoma
Daphne W. Bell et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
The Emerging Role of the Microenvironment in Endometrial Cancer
Subhransu S. Sahoo et al.
CANCERS (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
CD83 Modulates B Cell Activation and Germinal Center Responses
Lena Krzyzak et al.
JOURNAL OF IMMUNOLOGY (2016)
The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation
Alexandros Iliadis et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2016)
CD1a-positive dendritic cell density predicts disease-free survival in papillary thyroid carcinoma
Ohad Hilly et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Intratumoral CD68-, CD117-, CD56-, and CD1a-positive immune cells and the survival of Iranian patients with non-metastatic intestinal-type gastric carcinoma
Sakineh Amoueian et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Increase of DC-LAMP plus mature dendritic cell subsets in dermatopathic lymphadenitis of mycosis fungoides
Kotaro Tada et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2014)
High Endothelial Venule Blood Vessels for Tumor-Infiltrating Lymphocytes Are Associated with Lymphotoxin β-Producing Dendritic Cells in Human Breast Cancer
Ludovic Martinet et al.
JOURNAL OF IMMUNOLOGY (2013)
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+ T cells by plasmacytoid dendritic cells
Julien Faget et al.
ONCOIMMUNOLOGY (2013)
Distribution and Maturation of Skin Dendritic Cell Subsets in Two Forms of Cutaneous T-cell Lymphoma: Mycosis Fungoides and Sezary Syndrome
Philipp Schwingshackl et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells
Curdin Conrad et al.
CANCER RESEARCH (2012)
Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma
Jianjun Jia et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2012)
CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer
Seigo Kashimura et al.
GASTRIC CANCER (2012)
Tumor-Infiltrating Dendritic Cells May Be Used as Clinicopathologic Prognostic Factors in Endometrial Carcinoma
Zhao Lijun et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells
Stefan Nierkens et al.
CANCER RESEARCH (2011)
Recruitment and Differentiation of Conventional Dendritic Cell Precursors in Tumors
Jun Diao et al.
JOURNAL OF IMMUNOLOGY (2010)
Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
Eduardo J. Villablanca et al.
NATURE MEDICINE (2010)
Innate signaling by the C-type lectin DC-SIGN dictates immune responses
Jeroen den Dunnen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
CD83 polymorphisms and cervical cancer risk
Kelly J. Yu et al.
GYNECOLOGIC ONCOLOGY (2009)
Analysis of Dendritic Cells in Sentinel Lymph Nodes of Patients With Endometrial and Patients With Cervical Cancers
P. Pelin Kara et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells
Motohiro Nonaka et al.
JOURNAL OF IMMUNOLOGY (2008)
Aging and the dendritic cell system: Implications for cancer
Michael R. Shurin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response
Rebekah K. O'Donnell et al.
CANCER LETTERS (2007)
CD83 expression on dendritic cells and T cells: Correlation with effective immune responses
Cindy Aerts-Toegaert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin
KPJM van Gisbergen et al.
CANCER RESEARCH (2005)
Share Paper
